Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/248"
Predicate | Value (sorted: none) |
rdf:type |
|
rdf:type |
|
rdfs:label |
|
?:Evidence_type |
|
?:Evidence_enzyme_system |
|
dc:creator |
|
dc:date |
|
?:content |
"Enzyme system: For CYP1A2 - recombinant CYP450 enzymes expressed in an human lymphoblastoid cell system. For CYP2C9, 2C19,2D6, and 3A4 - recombinant CYP450 enzymes expressed in insect cells
NADPH added: yes
reaction: 1) ziprasidone --> ziprasidone sulphoxide
2) ziprasidone --> ziprasidone sulphone
Quote:
"The ability of specific CYP isoforms to metabolize
ziprasidone was determined using recombinant CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4. H.p.l.c.-radioactivity profiles of ziprasidone metabolites following incubation of [14C]-ziprasidone or [3H]-ziprasidone with CYP3A4 are shown in Figure 5(a) and (b), respectively. CYP3A4 catalysed the formation of the N-dealkylated metabolite (M5), as well as ziprasidone sulphone (M8) and ziprasidone sulphoxide (M10). These oxidative metabolites were not detected in incubations containing recombinant CYP1A2, CYP2C9, CYP2C19 or CYP2D6.""
|
rdfs:seeAlso |
|
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ ziprasidone_is_not_substrate_of_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsRefutingEvidence>, evidence_1764 }
Context graph